Leveraging melanocortin pathways to treat glomerular diseases.

Leveraging melanocortin pathways to treat glomerular diseases.

Item
http://www.wikidata.org/entity/Q37632054
Sex-specific effects of LiCl treatment on preservation of renal function and extended life-span in murine models of SLE: perspective on insights into the potential basis for survivorship in NZB/W female miceMelanocortin peptides: potential targets in systemic lupus erythematosusRepository corticotropin injection in a patient presenting with focal segmental glomerulosclerosis, rheumatoid arthritis, and optic neuritis: a case report.Acthar gel in the treatment of nephrotic syndrome: a multicenter retrospective case series.Adrenocorticotropic hormone analog use for podocytopathiesThe podocyte as a direct target for treatment of glomerular disease?Adrenocorticotropic hormone therapy for the treatment of idiopathic nephrotic syndrome in children and young adults: a systematic review of early clinical studies with contemporary relevance.Developments and new vistas in the field of melanocortins.Acquired Resistance to Corticotropin Therapy in Nephrotic Syndrome: Role of De Novo Neutralizing Antibody.Clinical and Economic Evaluation of Repository Corticotropin Injection: A Narrative Literature Review of Treatment Efficacy and Healthcare Resource Utilization for Seven Key IndicationsEfficacy and safety of adrenocorticotropic hormone treatment in glomerular diseases: a systematic review and meta-analysis.Low-dose synthetic adrenocorticotropic hormone-analog therapy for nephrotic patients: results from a single-center pilot study.Multiple Targets for Novel Therapy of FSGS Associated with Circulating Permeability Factor.Melanocortin 1 receptor agonist protects podocytes through catalase and RhoA activation.GPCRs as targets for approved drugs: How many targets and how many drugs?
P2860

Leveraging melanocortin pathways to treat glomerular diseases.

Item
http://www.wikidata.org/entity/Q37632054
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Leveraging melanocortin pathways to treat glomerular diseases.
@en
Leveraging melanocortin pathways to treat glomerular diseases.
@nl
type
label
Leveraging melanocortin pathways to treat glomerular diseases.
@en
Leveraging melanocortin pathways to treat glomerular diseases.
@nl
prefLabel
Leveraging melanocortin pathways to treat glomerular diseases.
@en
Leveraging melanocortin pathways to treat glomerular diseases.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P932
P356
P1433
P1476
Leveraging melanocortin pathways to treat glomerular diseases.
@en
P2093
P2860
P304
P31
P356
10.1053/J.ACKD.2013.09.004
P433
P478
P577
P698
P932